PT Soho Global Health Tbk (SOHO.JK)
IDR 635.0
(0.0%)
IDR 635.0
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 9.44 Billion IDR | -26.91% |
| 2022 | 12.91 Billion IDR | -30.33% |
| 2021 | 18.54 Billion IDR | -23.57% |
| 2020 | 24.25 Billion IDR | 0.0% |
| 2019 | - IDR | -100.0% |
| 2018 | 482.04 Billion IDR | 6.44% |
| 2017 | 452.88 Billion IDR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | - IDR | 0.0% |
| 2024 Q1 | 7.6 Billion IDR | 0.0% |
| 2024 Q2 | 7.47 Billion IDR | 0.0% |
| 2023 Q4 | 9.44 Billion IDR | 16.3% |
| 2023 FY | 9.44 Billion IDR | -26.91% |
| 2023 Q3 | 8.11 Billion IDR | -16.71% |
| 2023 Q2 | 9.74 Billion IDR | -8.36% |
| 2023 Q1 | 10.63 Billion IDR | -17.67% |
| 2022 Q3 | 18.78 Billion IDR | -1.41% |
| 2022 Q2 | 19.04 Billion IDR | 16.2% |
| 2022 Q1 | 16.39 Billion IDR | -11.58% |
| 2022 FY | 12.91 Billion IDR | -30.33% |
| 2022 Q4 | 12.91 Billion IDR | -31.22% |
| 2021 Q4 | 18.54 Billion IDR | -4.18% |
| 2021 Q3 | 19.34 Billion IDR | -7.47% |
| 2021 Q2 | 20.9 Billion IDR | 2.24% |
| 2021 Q1 | 20.45 Billion IDR | -15.69% |
| 2021 FY | 18.54 Billion IDR | -23.57% |
| 2020 Q4 | 24.25 Billion IDR | 19.72% |
| 2020 Q1 | 21.03 Billion IDR | 0.0% |
| 2020 FY | 24.25 Billion IDR | 0.0% |
| 2020 Q3 | 20.26 Billion IDR | 0.0% |
| 2019 Q4 | - IDR | 0.0% |
| 2019 FY | - IDR | -100.0% |
| 2019 Q1 | - IDR | 0.0% |
| 2018 FY | 482.04 Billion IDR | 6.44% |
| 2017 FY | 452.88 Billion IDR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| PT Enseval Putera Megatrading Tbk. | 2.36 Billion IDR | -299.11% |
| PT Itama Ranoraya Tbk | 502.93 Million IDR | -1776.964% |
| PT Kimia Farma (Persero) Tbk | 972.97 Billion IDR | 99.03% |
| PT Millennium Pharmacon International Tbk | 44 Billion IDR | 78.545% |